Literature DB >> 6268649

The development and evaluation of a solid-phase radioimmunoassay (RIA) procedure for the determination of susceptibility to varicella.

A Campbell-Benzie, H O Kangro, R B Heath.   

Abstract

The development of a sensitive solid-phase radioimmunoassay (RIA) procedure for the detection of specific antibodies against varicella-zoster (VZV) is described. The test proved to be about 200 times more sensitive than complement fixation (CF) and far more efficient at detecting low levels of antibody in the sera of individuals with past history of varicella. It is suggested that this RIA-VZV test would be suitable for distinguishing between individuals who are either immune or susceptible to varicella, which could be useful in a variety of clinical situations but particularly in current and future evaluations of varicella vaccines.

Mesh:

Substances:

Year:  1981        PMID: 6268649     DOI: 10.1016/0166-0934(81)90033-1

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  6 in total

1.  Detection of specific IgM in varicella and herpes zoster by antibody-capture radioimmunoassay.

Authors:  H O Kangro; A Ward; S Argent; R B Heath; J E Cradock-Watson; M K Ridehalgh
Journal:  Epidemiol Infect       Date:  1988-08       Impact factor: 2.451

2.  Hotting-up the complement-fixation test.

Authors:  C J Ronalds; A E Hardiman; P D Griffiths
Journal:  J Hyg (Lond)       Date:  1983-02

3.  Efficacy of varicella vaccine in patients with solid tumours.

Authors:  R B Heath; J S Malpas; H O Kangro; A Ward; J M McEniery; J E Kingston
Journal:  Arch Dis Child       Date:  1987-06       Impact factor: 3.791

Review 4.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

5.  Determination of specific IGA antibodies to varicella zoster virus by immunoperoxidase assay.

Authors:  H Haikin; I Sarov
Journal:  J Clin Pathol       Date:  1982-06       Impact factor: 3.411

6.  Serum immunoglobulin A antibody to varicella-zoster virus in subjects with primary varicella and herpes zoster infections and in immune subjects.

Authors:  A E Wittek; A M Arvin; C M Koropchak
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.